| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |